NR3C2 and neoplasm: Results from similar analyses in tumor specimens from our patient cohort, based on the determination of the proportion of both CD34 and MR positive cells in the different members of this group, show that CD34 expression was low in 12 subjects, intermediate in 2 subjects, and high in 16 subjects while MR expression was low in 17 subjects, and high in 13 subjects (Fig. 1).